RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Maturity-Onset Diabetes of the Young: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Explainable Machine Learning for the Prioritization of Variants of Uncertain Significance in Monogenic Diabetes Genes
EBENEZER A. MARADESA, Research Square (13 October 2026)
https://doi.org/10.21203/rs.3.rs-11297260/v1
- 2.
The Clinical Spectrum and Significance of ABCC8 Gene Variants in the Diagnosis of Monogenic Diabetes
Natalia Kapelan et al., Diabetology (13 October 2026)
https://doi.org/10.3390/diabetology7100199
- 3.
Genetic background modulates MafA
Loyd Zachary et al., Diabetologia (11 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42860432/
- 4.
Maturity-onset diabetes of the young and related monogenic diabetes: molecular mechanisms, genotype-directed treatment, and diagnostic pathways
Kehinde Sowunmi, Journal of Biochemical and Clinical Genetics (10 October 2026)
https://doi.org/10.24911/jbcgenetics.11-2956
- 5.
Integrative Bioinformatics Analysis Incorporating Artificial Intelligence and Machine Learning Identifies Putative Pathogenic HNF1B Missense Variants Associated with HNF1B-MODY
Hitham Aldharee, International Journal of Molecular Sciences (9 October 2026)
https://doi.org/10.3390/ijms27208966
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Maturity-Onset Diabetes of the Young
Maturity-onset diabetes of the young (MODY) is a group of inherited forms of diabetes caused by a change in a single gene. It usually appears in adolescence or early adulthood and is often mistaken for type 1 or type 2 diabetes. Treatment depends on the gene involved, and may include diet alone, tablets or insulin. Genetic testing helps guide care for the person and their family.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Maturity-Onset Diabetes of the Young?
Maturity-onset diabetes of the young (MODY) is a group of inherited forms of diabetes caused by a change in a single gene. It usually appears in adolescence or early adulthood and is often mistaken for type 1 or type 2 diabetes. Treatment depends on the gene involved, and may include diet alone, tablets or insulin. Genetic testing helps guide care for the person and their family.
How many clinical trials are available for Maturity-Onset Diabetes of the Young?
RareWays currently indexes 15 clinical trials for Maturity-Onset Diabetes of the Young, of which 4 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Maturity-Onset Diabetes of the Young come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Maturity-Onset Diabetes of the Young.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.